慢性肾脏病患者住院率的实用性试验
这项开放标签、整群随机试验在141家初级保健诊所纳入11,182例慢性肾脏病、2型糖尿病和高血压患者,干预组接受基于电子健康记录的个人化算法识别患者并由实践促进者协助提供指南推荐治疗,对照组接受常规照护。1年全因住院率干预组为20.7%(95%CI 19.7–21.8),常规照护组为21.1%(95%CI 20.1–22.2),组间差异0.4个百分点(P=0.58)。急诊就诊、再入院、心血管事件、透析或全因死亡风险两组相似;不良事件风险两组相似,但急性肾损伤在干预组更多(12.7% vs 11.3%)。在初级保健诊所中嵌入基于电子健康记录的算法和实践促进者未能转化为1年住院率降低。
要点
- 在141家初级保健诊所、11,182例慢性肾脏病合并2型糖尿病和高血压患者中,基于EHR的算法加实践促进者干预未降低1年全因住院率(20.7% vs 21.1%,P=0.58)。
- 干预组与常规照护组的急诊就诊、再入院、心血管事件、透析及全因死亡风险相似。
- 不良事件风险两组相似,但急性肾损伤在干预组更常见(12.7% vs 11.3%)。
- 该整群随机试验为开放标签设计,干预组71家诊所5690例,常规照护组70家诊所5492例。
适用人群与场景
- 在141家初级保健诊所接受治疗的慢性肾脏病、2型糖尿病和高血压(肾功能障碍三联征)患者,共11,182例。
处置流程与药物剂量
- 干预组:使用基于患者电子健康记录(EHR)的个人化算法识别患者,并由实践促进者协助提供者实施指南推荐的干预。
- 对照组:接受常规照护。
研究设计与关键结果
- 研究类型:开放标签、整群随机试验;141家初级保健诊所,11,182例患者;干预组71家诊所5690例,常规照护组70家诊所5492例。
- 主要终点:1年全因住院率干预组20.7%(95%CI 19.7–21.8) vs 常规照护组21.1%(95%CI 20.1–22.2),组间差异0.4个百分点,P=0.58。
- 次要终点:急诊就诊、再入院、心血管事件、透析或全因死亡风险两组相似。
- 不良事件:两组不良事件风险相似,但急性肾损伤在干预组更常见(12.7% vs 11.3%)。
证据类型、等级与局限
- 证据类型:开放标签、整群随机试验(ICD-Pieces,ClinicalTrials.gov NCT02587936)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在初级保健诊所中,基于EHR的个人化算法联合实践促进者未能降低慢性肾脏病、2型糖尿病和高血压患者的1年住院率,提示该干预策略在同类人群中未显示住院获益。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Despite the availability of effective therapies for patients with chronic kidney disease, type 2 diabetes, and hypertension (the kidney-dysfunction triad), the results of large-scale trials examining the implementation of guideline-directed therapy to reduce the risk of death and complications in this population are lacking.
METHODS: In this open-label, cluster-randomized trial, we assigned 11,182 patients with the kidney-dysfunction triad who were being treated at 141 primary care clinics either to receive an intervention that used a personalized algorithm (based on the patient's electronic health record [EHR]) to identify patients and practice facilitators to assist providers in delivering guideline-based interventions or to receive usual care. The primary outcome was hospitalization for any cause at 1 year. Secondary outcomes included emergency department visits, readmissions, cardiovascular events, dialysis, and death.
RESULTS: We assigned 71 practices (enrolling 5690 patients) to the intervention group and 70 practices (enrolling 5492 patients) to the usual-care group. The hospitalization rate at 1 year was 20.7% (95% confidence interval [CI], 19.7 to 21.8) in the intervention group and 21.1% (95% CI, 20.1 to 22.2) in the usual-care group (between-group difference, 0.4 percentage points; P = 0.58). The risks of emergency department visits, readmissions, cardiovascular events, dialysis, or death from any cause were similar in the two groups. The risk of adverse events was also similar in the trial groups, except for acute kidney injury, which was observed in more patients in the intervention group (12.7% vs. 11.3%).
CONCLUSIONS: In this pragmatic trial involving patients with the triad of chronic kidney disease, type 2 diabetes, and hypertension, the use of an EHR-based algorithm and practice facilitators embedded in primary care clinics did not translate into reduced hospitalization at 1 year. (Funded by the National Institutes of Health and others; ICD-Pieces ClinicalTrials.gov number, NCT02587936.).
参考来源
- Vazquez MA, Oliver G, Amarasingham R, et al. Pragmatic Trial of Hospitalization Rate in Chronic Kidney Disease. N Engl J Med. 2024. PMID: 38598574. doi:10.1056/NEJMoa2311708
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。